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Herpes simplex virus 1 (HSV-1) is composed of complex structures primarily characterized by four elements: the
nucleus, capsid, tegument and envelope. The tegument is an important viral component mainly distributed in the
spaces between the capsid and the envelope. The development of viral genome editing technologies, such as the
identification of temperature-sensitive mutations, homologous recombination, bacterial artificial chromosome, and
the CRISPR/Cas9 system, has been shown to largely contribute to the rapid promotion of studies on the HSV-1
tegument protein. Many researches have demonstrated that tegument proteins play crucial roles in viral gene
regulatory transcription, viral replication and virulence, viral assembly and even the interaction of the virus with
the host immune system. This article briefly reviews the recent research on the functions of tegument proteins
and specifically elucidates the function of tegument proteins in viral infection, and then emphasizes the significance
of using genome editing technology in studies of providing new techniques and insights into further studies of HSV-1
infection in the future.
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As a viral disease with an enormous impact on human
health, herpes simplex virus 1 (HSV-1) infection typically
generates uncomfortable, watery blisters on the skin
or on mucous membranes of the mouth and lips [1, 2]
and potentially leads to encephalitis with remarkable
sequelae or vesicle eruption on genital organ, with an
increasing incidence in recent years [3]. Importantly, the
eruption of these blisters and vesicles are frequently
attributed to the long-term latent infection of HSV-1 in
the nervous system [4]. Instead, the clinical symptoms of
acute infection, as well as the long-term pathologic
processes induced by recurrent latent infection, have
been shown to closely correlate with the complex viral
genome structures and the molecular mechanism of viral
gene transcriptional regulation and replication [5, 6].
The basic structure of HSV-1 consists of four ele-
ments: the core and capsid are composed of a double-
stranded DNA genome and viral DNA binding proteins* Correspondence: liqihan@imbcams.com.cn
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layer between the capsid and the envelope; the envelope
is the outer layer of the virion and is composed of an
altered host membrane and a dozen unique viral glyco-
proteins. Many previous studies on viral structures have
demonstrated that the tegument proteins are a group of
viral structural components playing an important role in
viral gene replication and virion assembly [7]. Many
researchers have undertaken substantial studies on tegu-
ment proteins for a long time. In the 1970s, Abodeely
et al. isolated a complete and purified HSV-1 particle
from hamsters with viremia and subsequently identified
20 structural proteins by polyacrylamide gel electrophor-
esis (PAGE) [8]. Spear and Heine et al. identified 24
structural proteins by optimizing the viral purification
assay [9, 10], of which vhs and VP16 were first defined
for the first time due to their essential functions in viral
infection and gene transcriptional regulation [11, 12].
Subsequently, several tegument proteins associated with
viral DNA transport into and out of the nucleus for viral
assembly have been identified: VP22 with a crucial role
in viral gene transcriptional regulation and virion capsidle is distributed under the terms of the Creative Commons Attribution 4.0
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targeting of incoming capsids to the nucleus and the re-
lease of the viral genome into the nucleus [14]; UL31,
Us3, ICP34.5, UL36, UL37 and UL51 required for regu-
lating viral nuclear egress; other proteins, including
UL36, UL37, UL11, UL20 and UL46-49, associating with
the primary envelopment of HSV-1.
In the 1970s, the establishment and development of
protein mass spectrometry rapidly promoted and facili-
tated further studies on tegument proteins, which
thereby largely contributed to the identification of sev-
eral proteins with small content or low molecular
weight. Loret et al. identified four tegument protein-
s—UL7, UL23, UL50 and UL55—by mass spectrometry
in 2008 and concomitantly confirmed the feature of
tegument proteins for ICP0 and ICP4, regardless of the
long term argument for their biological features [15].
Thereafter, the function of UL7 was determined to be
closely associated with the virulence and virion assembly
and egress from the envelope [16, 17]. UL50 was seen to
play an essential role in neurovirulence induction and in
nucleotide metabolism [18]. Although the network of
viral protein interactions has been gradually established
for clarifying the function of multiple tegument proteins
via the use of many assays, such as biochemical analyses,
yeast two hybrids and co-immunoprecipitation [19], re-
search on the immune response in humans to viral in-
fection has just been initiated. An increasing number of
studies have demonstrated the crucial roles of multiple
tegument proteins, including ICP0 and Us3 in inducing
interferon production and subsequently activating the
immune response in hosts. Collectively, these findings
appear to suggest the potential role of the tegument
proteins in the development of new vaccines and drugs
for protection from viruses and in the treatment of viral
diseases. In this article, the function of the HSV-1 tegu-
ment proteins is briefly described for a better under-
standing of their potential application in clinical studies.
Early studies on tegument proteins
vhs is first identified as one of the tegument proteins for
playing an important role in the early stage of viral in-
fection in cells. Nishioka et al. discovered that HSV in-
fection in Friend erythroleukemia cells (FL cells) could
lead to the inhibition of globulin synthesis and the
degradation of globulins encoding RNA [20, 21]. Schek
et al. observed that HSV-1 infection in Vero cells was
linked to the degradation of actin, tubulin and histone
mRNAs [11]. With the development of viral DNA muta-
tion technology, genomics and proteomics, Oroskar
et al. identified a temperature-sensitive mutant strain
with greatly improved cellular mRNA stability during
infection [22]. This finding was subsequently confirmed
to be related to the vhs tegument protein [23]. The vhstegument protein was found to function in the cellular
mRNA degradation process at an early stage of viral in-
fection. In the next ten years, an increasing number of
functions of the vhs protein have been described as fol-
lows: the vhs protein is a tegument protein of 58 kDa
encoded by the UL41 gene and enable of entering cells
to induce mRNA degradation; vhs is subsequently re-
sponsible for guiding cells from a state of host protein
synthesis to viral protein synthesis; the vhs protein has
been shown to consecutively promote the transcription
of viral mRNA and to facilitate the maintenance of the
expression of viral genes after the initiation of viral gene
transcription [24]. Everly and Read discovered the bio-
logical features of the vhs protein and its activity of an
RNA enzyme for inducing RNA degradation in cells, in-
cluding the degradation of viral mRNA via its presence
or simply by its interaction with cellular transcriptional
initiator 4H [25]. In infected cells, vhs exhibits a specific
selection for terminal mRNA molecules and first triggers
mRNA degradation in the 5′ terminal sequence of the
translation initiating domain prior to the degradation of
the 3′ terminal sequence [26]. In contrast, this limited
characteristic of vhs is failed to exhibit in purified virions
due to the absence of specific regions for RNA degrad-
ation [27]. All of these findings are most likely to imply
that the potential interaction of specific cellular proteins
and vhs is typically lacking in purified virions; which
thereby makes the vhs failing to display the specific site
selection of mRNA molecules triggered in cells [28]. In
recent years, researchers also noted that mRNA degrad-
ation by vhs could potentially be regulated by its inter-
action with the tegument protein UL47 [29].
The function of another well-known tegument protein,
VP16, in viral gene expression and regulation has been
studied since the 1980s. The HSV-1 gene expression cas-
cade in terms of immediate early, early, and late genes
was demonstrated to be strictly controlled. In particular,
during the early stages of a viral infection, a viral struc-
tural protein was identified to induce immediate early
gene expression as a result of its presence in the cellular
environment with the inactivated HSV-1 [30]. Campbell
et al. co-transfected a chimeric plasmid containing indi-
vidually cloned HSV-1 genomic fragments and immedi-
ate early gene-controlled thymidine kinase genes into
cells for localizing the regulatory factor of this gene at
the EcoRII enzyme-cutting site (the axis in viral genome
is 0.635–0.721) by assaying thymidine kinase activity
[12]. Further gene cloning confirmed the identity of this
protein as ICP25 (now named VP16). The transcrip-
tional regulation of VP16 on the viral IE gene was
determined by a common co-motif (the sequence is
TAATGARAT) with one or multiple copies in the up-
stream region of a specific IE initiating domain [31, 32].
Nevertheless, VP16 was not shown to individually bind
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Rather, VP16 played a role in transcriptional regulation via
the interaction of the cellular transcriptional factor OCT-I
with the octamer sequence (containing TAATGARAT
motif) and the host cell factor-1 (HCF-1) [33, 34].
The developmental studies of tegument proteins
Before the 1990s, the identification and localization of
HSV-1 proteins appeared to merely depend upon mu-
tant viral strains that were temperature-sensitive and on
the marker rescue assay, which thereby led to limitations
in studying its related functions. In 1992, Shizuya et al.
constructed the first bacterial artificial chromosome
(BAC) vector BAC108L based upon an F1 factor back-
bone of Escherichia coli with an insertion of a 300 kb
DNA fragment [35]. This approach was mainly applied
to identify the specific deletion, which greatly promoted
the studies of HSV-1 viral gene functions. Additionally,
the development and employment of mass spectrometry
largely contributed to facilitating the identification of
four new tegument proteins, UL7, UL23, UL50 and
UL55, as well as the classification of the ICP0 and ICP4
proteins as tegument proteins [15]. These findings will
be individually described in the following paragraph.
Viral gene transcriptional regulation factor
All the Herpesviruses have been found to exhibit the
cascade of immediate early genes, early genes, and late
genes in viral replicative gene expression, during which
multiple tegument proteins are speculated to be largely
involved. When a viral genomic DNA molecule enters
into the nucleus, the VP16 viral protein first initiates a
gene transcriptional event to enable cis-activation of the
transcription of the immediate early proteins ICP0, ICP4,
ICP22, ICP27 and ICP47. Upon production of ICP0, ICP0
and the nuclear domain 10 (ND10) sub-structure co-
distribute within spots in the nucleus. The viral protein
ICP0 subsequently induces SUMO-1-modified PML and
sp100 to damage the ND10 structure via a protease
pathway within several hours and stimulate viral infection
and cis-activate early gene and late gene transcription
[36]. Furthermore, ICP0 is evidenced to enhance early and
late gene transcription by neutralizing the inhibitory
activity associated with the HDAC amino terminal by
interacting with the HDAC 4, 5, 7 amino terminals [37].
Another transcriptional regulatory factor required for
establishing HSV-1 infection is ICP4 responsible for
modulating HSV-1 replication and transcription required
for balancing the HSV-1 entry into the infectious or latent
state. ICP4 is able to negatively modulate the ICP4
promoter, the latency-associated promoters and long and
short junction-spanning transcripts (L/ST) promoters
[38–40]. ICP4 can activate the early and late gene tran-
scription of a vast majority of viruses by acting as animportant transcriptional activating factor. ICP4 exhibits a
specific affinity to DNA sequences by acting as a DNA
binding protein. On the base of analyzing the known
individual ICP4 binding domains, researchers summarize
a group of DNA sequences with specific regularity i.e.,
RTCGTCNNYNYSG, of which R is purine, Y is pyrimi-
dine, S is C or G, and N is any base [41].
Additionally, many studies have substantially evi-
denced the essential function of Us3 in viral gene ex-
pression and maturation. Us3 has been shown to repress
histone deacetyltransferases and enhance viral gene
expression via phosphorylating histone deacetylase 1
(HDAC-1) and HDAC-2 [42]. Some studies have dem-
onstrated that UL14 could indirectly modulate immedi-
ate early gene transcription by expediting VP16 entry
into the nucleus at the early stages of infection [43]. An
in vitro cell culture assay revealed that the infection of
the UL13 deletion mutant viral strain with cells could
lead to a decrease in the expression levels of the ICP0,
UL26, UL26.5, UL38, vhsand Us11 [44].
Viral genome replication-associated UTPase protein
dUTP is hydrolyzed to dUMP and pyrophosphate via
dUTP enzyme catalysis. Because it is easier for DNA
polymerase to introduce dUTP into the DNA strand
during replication and in the generation of point muta-
tions or strand breaks, the hydrolyzation of dUTP by the
dUTP enzyme is required for the precise replication of
DNA [45]. The functions of viral UL50 have gradually
been got to know since the classification of UL50 as a
tegument protein by Loret et al. UL50 was identified to
encode the dUTP enzyme required for viral replication.
dUTP is also involved in nucleotide metabolism, which
plays an essential role in viral replication. Akihisa Kato
et al. observed that the UL50 encoding dUTP enzyme
had the capacity to interact with cellular dUTP to co-
operatively expedite precise viral gene replication. Fur-
thermore, viral dUTP enzyme activity was typically
shown to depend on the phosphorylation of serine187
by the Us3 protein [18]. In the subsequent experiment,
the neurovirulence of the virus was clearly eliminated,
and the mutation ratio of the viral genome was signifi-
cantly increased in infected mice upon serine 187 muta-
tion to alanine. The high expression of the dUTP
enzyme in cells was shown to clearly improve these bio-
logical effects, reduce genomic mutations and lead to
the recovery of neurovirulence [46].
Thymidine kinase (TK)
The HSV-1 UL23 gene encoding thymidine kinase (TK)
has received great attention for a long time. However,
TK was defined to be a member of the tegument protein
family for the first time by protein mass spectrometry in
2008 by Loret et al. TK is responsible for synthesizing
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sphate (TMP) and exhibits deoxycytidine kinase (dCK)
activity for phosphorylating deoxycytidine (dCyd) to
dCyd monophosphate. TK also act as thymidylate kinase
(TMPK) to phosphorylate TMP to thymidine diphos-
phate (TDP) [47, 48], as well as capable of phosphorylat-
ing acyclovir to acyclovir monophosphate, which is
directly linked to the repression of viral replication by
reducing DNA polymerase activity, and thereby makes
TK becoming an essential target for the development of
acyclovir anti-viral drugs and associated drug tolerance
studies.
Viral virulence-associated proteins
Chou et al. had previously reported that ICP34.5 was
closely associated with HSV-1 neurovirulence [49]. Sub-
sequent studies indicated that ICP34.5 could antagonize
Beclin 1-mediated autophagy. ICP34.5 was shown to re-
duce this protective function in the host via its inter-
action with the mammalian autophagy protein Beclin 1
[50]. The study of viral UL14 function was performed in
a mutant strain containing a UL14 deletion. UL14 is a
highly conserved protein of approximately 32 kDa
frequently phosphorylated and expressed at low levels in
the herpes virus family. The infection of cells with the
virus with a UL14 gene deletion at a low multiplicity of
infection (moi) displays a slow replication speed for
repressing viral release. When the mutant virus is intra-
cranially injected in mice, the 50 % lethal dosage is
shown to be reduced by over 30,000-fold, and the
number of recurrent infections in mice infected with this
mutant virus is remarkably reduced as well. All of these
data are sufficient to implicate the essential roles of
UL14 in viral replication and in the viral lytic and latent
infection processes [51]. The mutant strain with the UL7
gene deletion exhibits equally reduced replication and
plaque formation in Vero cells, which appears to suggest
the potential function of UL7 in viral virulence [16].
Viral transport and maturation-associated proteins
About half of the HSV-1 encoding tegument proteins
play essential roles in viral transport and maturation.
When HSV-1 attaches to cells, the majority of tegument
and envelope proteins are triggered to release from the
viral nucleocapsid. However, only a small number of
tegument proteins still bind to the nucleocapsid and
subsequently migrate into the nucleus. Us3, UL36 and
UL37 are not identified to release from the nucleocapsid.
Us3 is another protein kinase of HSV-1 that encodes a
serine/threonine kinase. Many studies have shown sub-
stantial evidence of the crucial function of Us3 in viral
gene expression and maturation. Us3 was shown to not
only expedite nucleocapsid transport from the nucleus
to the cytoplasm [52] but also to ensure the fusion ofthe viral envelope with the peripheral nuclear membrane
during viral egress from the nucleus by phosphorylating
the gB protein [53]. The UL36 protein is a highly con-
served tegument protein with low expression levels in
the herpes virus family. The study of UL36 started from
the construction and phenotype analysis of the tB7
temperature-sensitive mutant viral strain, but the study
remained stagnant until the construction of the mutant
viral strain with the UL36 deletion. The phenotype iden-
tification assay revealed that UL36 deletion could dir-
ectly contribute to viral nucleocapsid aggregation in the
cytoplasm and subsequently repressed capsid formation
and envelopment [54]. The study of UL36 localization
showed a characteristic peripheral distribution of UL36
at an early stage of viral infection, with de novo-
synthesized UL36 being distributed in the peripheral nu-
cleus, cytoplasm and rarely in the nucleus. The findings
of nucleocapsid aggregation in the mutant strain with a
UL36 deletion, as well as the characteristic distribution
of UL36 proteins are most likely to imply that UL36
might be a critical factor in expediting nucleocapsid
transport to the cytoplasm for tegument formation [55].
Importantly, the expedition of UL36 transport to the
nucleocapsid is speculated to mainly depend upon the
highly conserved nuclear localization sequences in the
neighboring N-terminal structural domain [56]. Add-
itionally, UL36was shown to promote the secondary
envelopment in virion assembly through its direct inter-
action with the UL37 protein in the N-terminal struc-
tural domain [57].
However, most of the tegument proteins have been
shown to release from the nucleocapsid upon attaching
to cells and subsequently to perform their functions in
viral envelopment. UL11, UL6, UL21, UL47, VP16 and
VP22 are closely associated with viral envelopment. The
mutant viral strain with the VP22 deletion exhibits a
remarkable repression on egress from the nucleus and
subsequent spread between cells, which allows for an
implications of several VP22 functions in virion assem-
bly and cellular egress with mechanisms remained
largely unknown [58]. VP16 is a classical transcriptional
regulatory factor with a crucial role in virion assembly.
A substantial nucleocapsids are aggregated in the cells
infected with the viral strain with the VP16 gene dele-
tion, and an increase in the virion with incomplete enve-
lopes is observed [59]. The virion with the incomplete
envelope produced in cells infected by the viral strain
with the UL11 gene deletion is increased by 2-3-fold
compared to cells infected with a wildtype strain [60].
Currently, there are few reports on the studies of UL16,
UL21 and UL47, and UL16 is speculated to involve in
envelopment as a result of its direct interaction with gE
proteins composed of essential envelope elements [61].
UL21 is presumed to associated with viral maturation
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observed in the mutant strain with the UL21 gene dele-
tion [62]. Zhuoming Liu et al. demonstrated that the
number of primary enveloped virions was reduced in the
perinuclear space, whereas the number of nucleocapsids
was clearly increased upon infection by the mutant strain
with the UL47 gene deletion. Thus, these findings are suf-
ficient to suggest the correlation to the interaction be-
tween UL47 and Us3 and UL31 and UL34 in cells [63].
New studies on tegument proteins
With the gradual understanding and revelation of poten-
tial functions of various tegument proteins in viral infec-
tion, scientists have started to emphasize the theoretical
knowledge on the practical significance in clinical drug
and vaccine development, of which the immune re-
sponse induced in viral infections is receiving the great-
est attention. Multiple members of tegument proteins
are generally recognized to be critical in inducing an im-
mune response in hosts. For example, Us3 has been
shown to down-regulate the expression of major histo-
compatibility complex I (MHC-I) on the surface of in-
flammatory cells to allow viruses for escaping from the
host immune response; to cooperatively interact with
glycoprotein gB for rapidly repressing the activation of
CD1d antigen delivery and natural killer T cells; to phos-
phorylate IFN regulatory factor 3 (IRF3) for repressing
the production of IFN-β. The Us3 protein kinase has
been shown to phosphorylate the α subunit of the INF-γ
receptor for repressing the expression of the INF stimu-
lating gene (ISG) induced by IFN-γ [64–66]. Us3 has
been shown to phosphorylate serine 75 on p65 for
repressing p65 nuclear trans-localization and the activa-
tion of the NF-kB pathway and to down-regulate inflam-
matory cytokine IL-8 levels for subsequently repressing
the immune response induced by viral infection [67]. In
a study of investigating the HIV super-infection course
by HSV-1, the functions of the finger-ring structure of
ICP0 and the ubiquitin ligase E3 were shown to be
involved in a number of signaling pathways in cells.
ICP0 has the capacity to block the anti-viral response
induced by interferons during the early stages of viral
infection through the specific inhibition of the cellular
response mediated by interferon-regulated factor 3 (IRF3)
and IRF7 [68].
Additionally, in the research and development on pre-
ventive or treatment vaccines, more and more tegument
proteins have been demonstrated to be potential targets
for constructing live attenuated vaccines. vhs, ICP0,
ICP4, ICP34.5, UL14 and UL7 are associated with host
mRNA degradation, viral gene transcriptional regulation
and viral virulence rather than being required for viral
growth, which are equally speculated to be good targets.
The mutant strains with deletions in these genes havesuccessfully been constructed and exhibit remarkably re-
duced viral pathogenicity by using the classical BAC ap-
proach. Nevertheless, the virulence of these mutants has
not been sufficiently eliminated to receive attention.
Notably, the Zhang Lab first reported on a CRISPR-Cas9
system that was originally observed in bacteria and ar-
chaea as an adaptive microbial immune system mediated
by a long-term selection pressure of bacteriophages [69].
This technology brings new hope for precise editing of
DNA viruses and the development of HSV-1 vaccines.
The CRISPR-Cas9 system consists of segments of pro-
karyotic DNA identified by complementary base pairing
of short CRISPR RNAs functioning as guiding strands to
direct the Cas9 nuclease to the complementary invading
DNA. Subsequently, homologous recombination or non-
homologous end joining is induced to edit the target
DNA. The discovery of the CRISPR-Cas9 system has
provided a powerful tool for scientists to specifically tar-
get the efficient modification of the invading DNA gen-
ome. For the first time, Yan Wei and TadahiroSuenaga
et al. used the CRISPR- Cas9 system to conduct the pre-
cise editing of a DNA virus with a complicated genome
structure at high efficiency without off-target effects [70,
71]. Wang J et al. attempted to knock out the EBV (Ep-
stein-Barr virus) latency-associated gene by using the
CRISPR-Cas9 system for the potential treatment of la-
tent EBV infection. Rajia cells isolated from patients
with latent EBV infections and Burkitt’s lymphoma were
treated with CRISPR-Cas9-associated plasmids, and the
cell replication and EBV load in cells, respectively, were
shown to be remarkably reduced [72]. These findings are
most likely to suggest the potential application of the
CRISPR-Cas9 system in vaccine development and in the
treatment of viral diseases.
Conclusion
With regard to tegument proteins, studies on the UL11,
UL16, UL21, UL7 and UL55 proteins have primarily
been initiated. In light of the undertakings on herpes
virus family members, such as VZV, EBV and HCMV,
the modification of the viral genome and the proteins
associated with using various technologies have greatly
promoted virus-associated research. In the 1980s, scien-
tists could only modify viruses by using temperature-
sensitive mutations and homologous recombination
assays, with the subsequent identification of target
functional proteins via the marker rescue assay. Thus,
the studies of HSV-1-associated proteins have been re-
stricted to viral proliferation or replication-associated
molecules, in which the essential functions of the tegu-
ment proteins ICP0, ICP4, vhs and VP16 in viral gene
transcriptional regulation are defined.
Despite the difficulties in construction, the time-
consuming process, and the low mutation rate, the BAC
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proteins. This system has played the most important role
in HSV-1 studies. The vast majority of mutant viral
strains with tegument deletions have successfully been
constructed for the past 20 years since the establishment
of BAC system. Together with the development of yeast
two hybrids, pull-down assays, co-immunoprecipitation
and chromatin co-immunoprecipitation technologies,
the functions and mechanisms of viral gene transcriptional
regulatory factors, viral virulence associated proteins, viral
dUTP enzymes, viral transport and maturation-associated
proteins have primarily been described and defined.
However, due to the restriction to low efficiencies and
high difficulties in the BAC system, the mutant viral
strains with two or multiple gene deletions are still
difficult to be constructed, which simultaneously leads to
a restriction in the construction of viral protein interaction
networks and a comprehensive understanding of HSV-1
proteomics.
Surprisingly, the development of the CRISPR-Cas9
system provides a new technique for studying HSV-1
proteins, enabling the generation of precise mutations in
the HSV-1 gene within a short period of time. Further-
more, the experiment is simple and will not leave any
trail of the viral genome when the genetic mutation is
performed. Currently, a mutant viral strain with a point
mutation and gene deletion have been successfully
constructed by using the CRISPR-Cas9 system, and the
function and correlated mechanisms of this protein have
been subsequently explored by using pull-down and chro-
matin co-immunoprecipitation assays. In future studies,
scientists may be able to construct mutant viral banks
with multiple genetic mutations of interest, which could
not only extensively be used to further analyze protein
functional mechanisms and protein interaction networks
but also to provide new exploratory and thinking ap-
proaches for preventing and treating against HSV-1 infec-
tions that pose a great threat to human health.
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